Clinical Trial Update: Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Capizzi-escalating methotrexate to high-dose methotrexate in children with newly diagnosed T-cell lymphoblastic lymphoma is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Children's Cancer Group, China | Conditions: T-cell Lymphoblastic Lymphoma | Phase 3 | Status: RECRUITING